Skip to main content
Home

Dedicated to discovery

  • Company
    • About us
    • Careers
    • Events
  • Support
    • Laboratory Planning
    • Register a Product
    • Register Your Product (USA & Canada Only)
  • Contact
  • U.S.A.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 日本
  • 中国
Home
  • Products
    • PURELAB®
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 2 +
      • PURELAB® Chorus 3
      • PURELAB® flex 1
      • PURELAB® flex 2
      • PURELAB® flex 3
      • PURELAB® flex 4
      • PURELAB® flex 5
    • CENTRA®
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA®
      • MEDICA® 7/15
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE®
      • BIOPURE® 300/600
    • ELGA Full Product Range
      • PURELAB® Classic
  • Applications
    • Atomic Absorption Spectroscopy
    • Cell and Tissue Culture
    • Clinical Biochemistry
    • Electrochemistry
    • Gas Chromatography
    • General lab water requirement
    • Immunochemistry
    • Liquid Chromatography
    • Mass Spectrometry
    • Microbiology
    • Molecular Biology
    • Spectrophotometry
  • Technologies
    • Activated Carbon
    • Electrodeionization (EDI)
    • Filtration
    • Ion Exchange
    • PureSure
    • Reverse Osmosis
    • Ultraviolet
  • Impurities In Water
    • Dissolved Gases
    • Inorganic Compounds
    • Microorganisms & Bacteria
    • Organic Compounds
    • Particulates
  • Knowledge
    • Blog
    • Case Studies
    • Ultrapure water
    • Guides and White Papers
  • Where to buy
  • Contact us
Home
  • Contact us
  • Products
    • PURELAB®
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 2 +
      • PURELAB® Chorus 3
      • PURELAB® flex 1
      • PURELAB® flex 2
      • PURELAB® flex 3
      • PURELAB® flex 4
      • PURELAB® flex 5
    • CENTRA®
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA®
      • MEDICA® 7/15
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE®
      • BIOPURE® 300/600
    • ELGA Full Product Range
      • PURELAB® Classic
  • Applications
    • Atomic Absorption Spectroscopy
    • Cell and Tissue Culture
    • Clinical Biochemistry
    • Electrochemistry
    • Gas Chromatography
    • General lab water requirement
    • Immunochemistry
    • Liquid Chromatography
    • Mass Spectrometry
    • Microbiology
    • Molecular Biology
    • Spectrophotometry
  • Technologies
    • Activated Carbon
    • Electrodeionization (EDI)
    • Filtration
    • Ion Exchange
    • PureSure
    • Reverse Osmosis
    • Ultraviolet
  • Impurities In Water
    • Dissolved Gases
    • Inorganic Compounds
    • Microorganisms & Bacteria
    • Organic Compounds
    • Particulates
  • Knowledge
    • Blog
    • Case Studies
    • Ultrapure water
    • Guides and White Papers
  • Where to buy
  • Contact us
  • Company
    • About us
    • Careers
    • Events
  • Support
    • Laboratory Planning
    • Register a Product
    • Register Your Product (USA & Canada Only)
  • Contact
  • U.S.A.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 日本
  • 中国
  • Privacy policy
  • Terms & Conditions
  • Global Legal Compliance
  • Patents
  • Trademarks
  • Impressum

Let's talk about lab water

  • Categories
    • Analytical Chemistry
    • Biotechnology
    • Clinical & Pharma
    • Cool Science
    • Environment & Sustainability
    • Future Science
    • Life in The Lab
    • Life Science Results
    • PURELAB Product Design
    • Science of the Future
    • Water In The Lab
    • Water Purity
  • Authors
    • ELGA Editorial Team_cloned
    • ELGA Editorial Team
    • Natasha Zarach
    • Dr Paul Whitehead
    • Dr Alison Halliday
    • John Walker
Clinical & Pharma
Analytical Chemistry

Searching For Antivirals For COVID–19

18 Oct 2021
- by Dr Alison Halliday

COVID Testing

Researchers develop a new analytical method to support clinical trials exploring the antiviral drug, molnupiravir, as a COVID–19 treatment.

Over the past 20 years, emerging coronaviruses from animal reservoirs have caused severe and lethal diseases in humans – including SARS–CoV, MERS and SARS–CoV–2, which causes COVID–19. Early in the COVID–19 pandemic, researchers turned to novel and repurposed antivirals to search for effective new treatments for the disease.

Remdesivir, originally developed for the treatment of Hepatitis C and Ebola, has now been approved for treating patients with severe COVID–19. But this drug must be given to patients intravenously – requiring hospitalisation – and it is difficult to manufacture and expensive. Researchers are continuing the hunt for other antiviral medicines for treating COVID–19.

A Candidate Oral Drug

Molnupiravir (MPV), is an oral antiviral drug currently in clinical trials for the treatment of COVID–19. Taken as a prodrug, MPV is converted to its active form in the cell, ß–d–N4–hydroxycytidine (NHC). MPV was one of the first drugs selected for testing on the Accelerating COVID–19 Drug Development – Phase I/II platform (AGILE), which was launched early in the pandemic to fast–track the evaluation of potential new treatments for the disease.

Understanding how a drug is absorbed, distributed, metabolised and eliminated from the body is an important part of early-stage clinical trials. These clinical pharmacokinetics studies require analytical methods that can accurately measure the concentration of target analytes in the body.

Pharmacokinetics of MPV and NPC

The AGILE team set out to develop a simple and sensitive new liquid–chromatography/tandem mass spectrometry (LC–MS/MS) method for the simultaneous quantification of MPV and NHC in plasma and saliva.1

The team extracted the analytes from samples by protein precipitation, followed by chromatographic separation. They then conducted analyte detection in negative ionisation mode, performing the analysis using stable isotopically labelled internal standards.

Their new method was validated according to the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) guidelines over a linear range of 2.5–5000 ng/ml for both plasma and saliva. Across four different concentrations, precision and accuracy were 15% – and the recovery of both analytes from plasma and saliva was between 95% and 100% and 65–86% respectively.

The team used ultrapure water generated from an ELGA PURELAB® laboratory water purification system, minimising the risk of introducing contaminants that may affect their results.

A Bespoke method

The researchers present a sensitive, selective, accurate and robust new LC–MS/MS method that is validated to quantify MPV and NPC in human plasma and saliva. 

This bespoke method, which was devised for the AGILE trial, will help provide greater clarity about the clinical pharmacokinetics of MPV and NPC under different treatment scenarios – forming the basis of selecting the most effective dose regimen.

Additionally, this assay can serve as the foundation method for other trials involving the same analytes. 

Why Choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.

 

Reference:

1) Amara, A.A. et al. The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß–d–N4–hydroxycytidine in human plasma and saliva. J Pharm Biomed Anal. 2021;206:114356

 

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

Quest Download

PURELAB Quest

The only purifier on the market that dispenses all 3 types of science ready water from a compact, economical and easy to use system!

             Click Here To Find Out More

 

Explore more from our blog

27 Mar 2023
How does a plant-based diet affect the mineral content of breast milk?
9 Mar 2023
Identifying antibacterial compounds in industrial hemp
27 Feb 2023
Single-cell suspensions from the human placenta
16 Jan 2023
Measuring the effects of indoor air pollution
10 Jan 2023
A novel approach to wound healing
12 Dec 2022
3D bioprinting probiotics capsules
4 Nov 2022
Wie mikrobielle Brennstoffzellen zur Lösung von zwei dringenden globalen Umweltproblemen beitragen könnten
24 Oct 2022
New ‘designer drug’ identified in e-cigarettes

Blog Categories

  • Analytical Chemistry
  • Biotechnology
  • Clinical & Pharma
  • Cool Science
  • Environment & Sustainability
  • Future Science
  • Life in The Lab
  • Life Science Results
  • PURELAB Product Design
  • Science of the Future
  • Water In The Lab
  • Water Purity
  • Enquiry
  • Get a Quote
  • Book a Demo
  • Find an Approved Partner

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Get a Quote

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Book a Demo

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Headquarters

ELGA LabWater North America
5 Earl Ct Suite 100
Woodridge, IL 60517
USA

Tel: 630-343-5251

ELGA LabWater UK Headquarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Case Studies

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Olsberg Vocational College

Resources

  • Learn About Ultrapure Water
  • Guides and White Papers
  • Purification Technologies
  • Applications
  • Impurities In Water

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd. trading as ELGA LabWater. 2023 - All rights reserved.
ELGA is the global laboratory water brand name of Veolia.

  • Privacy policy
  • Terms & Conditions
  • Global Legal Compliance
  • Patents
  • Trademarks
  • Impressum
  • Language
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Other Veolia Sites
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia